Presentation is loading. Please wait.

Presentation is loading. Please wait.

BRCA1 and BRCA2 Testing: Weighing the Demand against the Benefits

Similar presentations


Presentation on theme: "BRCA1 and BRCA2 Testing: Weighing the Demand against the Benefits"— Presentation transcript:

1 BRCA1 and BRCA2 Testing: Weighing the Demand against the Benefits
P. Devilee  The American Journal of Human Genetics  Volume 64, Issue 4, Pages (April 1999) DOI: /302350 Copyright © 1999 The American Society of Human Genetics Terms and Conditions

2 Figure 1 Comparison of cumulative breast cancer risk estimates conferred by BRCA1 and BRCA2. The estimates of the Breast Cancer Linkage Consortium are taken from Ford et al. (1995; 1998), whereas those for the 185delAG mutation in BRCA1 and the 999del5 mutation in BRCA2 were taken from Struewing et al. (1997) and Thorlacius et al. (1998), respectively. The American Journal of Human Genetics  , DOI: ( /302350) Copyright © 1999 The American Society of Human Genetics Terms and Conditions


Download ppt "BRCA1 and BRCA2 Testing: Weighing the Demand against the Benefits"

Similar presentations


Ads by Google